DEAFNESS, AUTOSOMAL DOMINANT 66
|
disease |
|
Disease or Syndrome
|
1
|
|
0.600 |
limited |
1.000 |
1 |
|
2015 |
2015 |
Abortion, Tubal
|
phenotype |
Female Urogenital Diseases and Pregnancy Complications
|
Pathologic Function
|
109
|
|
0.300 |
None |
1.000 |
1 |
|
2008 |
2008 |
Early Pregnancy Loss
|
phenotype |
Female Urogenital Diseases and Pregnancy Complications
|
Finding
|
109
|
|
0.300 |
None |
1.000 |
1 |
|
2008 |
2008 |
Squamous cell carcinoma of mouth
|
disease |
Digestive System Diseases; Neoplasms; Stomatognathic Diseases
|
Neoplastic Process
|
123
|
1
|
0.010 |
None |
1.000 |
1 |
|
2017 |
2017 |
Nonsyndromic Deafness
|
disease |
Pathological Conditions, Signs and Symptoms; Nervous System Diseases; Otorhinolaryngologic Diseases
|
Disease or Syndrome
|
163
|
66
|
0.310 |
limited |
1.000 |
1 |
|
2015 |
2015 |
Spontaneous abortion
|
phenotype |
Female Urogenital Diseases and Pregnancy Complications
|
Pathologic Function
|
188
|
|
0.300 |
None |
1.000 |
1 |
|
2008 |
2008 |
Sezary Syndrome
|
disease |
Neoplasms; Immune System Diseases; Hemic and Lymphatic Diseases
|
Neoplastic Process
|
196
|
7
|
0.020 |
None |
1.000 |
2 |
|
2014 |
2017 |
Aplastic Anemia
|
disease |
Hemic and Lymphatic Diseases
|
Disease or Syndrome
|
238
|
30
|
0.010 |
None |
1.000 |
1 |
|
2017 |
2017 |
Blood basophil count (lab test)
|
phenotype |
|
Laboratory Procedure
|
272
|
452
|
0.100 |
None |
1.000 |
1 |
1
|
2018 |
2018 |
Primary Myelofibrosis
|
disease |
Hemic and Lymphatic Diseases
|
Neoplastic Process
|
282
|
29
|
0.010 |
None |
1.000 |
1 |
|
2007 |
2007 |
Variable expressivity
|
phenotype |
|
Finding
|
319
|
|
0.100 |
None |
|
0 |
|
|
|
Lymphoma, T-Cell, Cutaneous
|
disease |
Neoplasms; Immune System Diseases; Hemic and Lymphatic Diseases
|
Neoplastic Process
|
367
|
5
|
0.030 |
None |
1.000 |
3 |
|
2014 |
2017 |
Miscarriage
|
disease |
Female Urogenital Diseases and Pregnancy Complications
|
Disease or Syndrome
|
426
|
56
|
0.300 |
None |
1.000 |
1 |
|
2008 |
2008 |
Tumor Initiation
|
phenotype |
Pathological Conditions, Signs and Symptoms; Neoplasms
|
Neoplastic Process
|
533
|
8
|
0.010 |
None |
1.000 |
1 |
|
2017 |
2017 |
hearing impairment
|
phenotype |
Pathological Conditions, Signs and Symptoms; Nervous System Diseases; Otorhinolaryngologic Diseases
|
Disease or Syndrome
|
740
|
337
|
0.010 |
None |
1.000 |
1 |
|
2015 |
2015 |
Sensorineural Hearing Loss (disorder)
|
disease |
Pathological Conditions, Signs and Symptoms; Nervous System Diseases; Otorhinolaryngologic Diseases
|
Disease or Syndrome
|
783
|
111
|
0.100 |
None |
|
0 |
|
|
|
Brain Neoplasms
|
group |
Neoplasms; Nervous System Diseases
|
Neoplastic Process
|
1018
|
204
|
0.010 |
None |
1.000 |
1 |
|
2019 |
2019 |
Prostatic Neoplasms
|
group |
Neoplasms; Male Urogenital Diseases
|
Neoplastic Process
|
1722
|
31
|
0.010 |
None |
1.000 |
1 |
|
2006 |
2006 |
Carcinoma of bladder
|
disease |
Neoplasms; Female Urogenital Diseases and Pregnancy Complications; Male Urogenital Diseases
|
Neoplastic Process
|
2104
|
309
|
0.010 |
None |
1.000 |
1 |
|
2018 |
2018 |
Malignant neoplasm of urinary bladder
|
disease |
Neoplasms; Female Urogenital Diseases and Pregnancy Complications; Male Urogenital Diseases
|
Neoplastic Process
|
2113
|
316
|
0.010 |
None |
1.000 |
1 |
|
2018 |
2018 |
Bladder Neoplasm
|
disease |
Neoplasms; Female Urogenital Diseases and Pregnancy Complications; Male Urogenital Diseases
|
Neoplastic Process
|
2130
|
281
|
0.010 |
None |
1.000 |
1 |
|
2018 |
2018 |
Adenocarcinoma
|
group |
Neoplasms
|
Neoplastic Process
|
2235
|
168
|
0.010 |
None |
1.000 |
1 |
|
1992 |
1992 |
Carcinoma
|
group |
Neoplasms
|
Neoplastic Process
|
2462
|
103
|
0.010 |
None |
1.000 |
1 |
|
2000 |
2000 |
Childhood Glioblastoma
|
disease |
Neoplasms
|
Neoplastic Process
|
2527
|
98
|
0.010 |
None |
1.000 |
1 |
|
2019 |
2019 |
Adult Glioblastoma
|
disease |
Neoplasms
|
Neoplastic Process
|
2528
|
98
|
0.010 |
None |
1.000 |
1 |
|
2019 |
2019 |